jcmm12317-sup-0001-FigS1.tifimage/tif538KFigure S1 C-Myc was predicted to be a potential target of miR-184 by RNAhybrid software.
jcmm12317-sup-0002-FigS2.tifimage/tif1895KFigure S2 C-Jun binding sites and its mutant sites in miR-184 promoter. MT1: The mutation of site 1; MT2: The mutation of site 2; MT1+2: The combined mutations of MT1 and MT2.
jcmm12317-sup-0003-FigS3.tifimage/tif358KFigure S3 The expression of miR-184 was suppressed by its specific inhibitor in A549 and SPCA1 cells.
jcmm12317-sup-0004-FigS4.tifimage/tif268KFigure S4 miR-184 did not regulate the expression of CCDC19 in NSCLC.
jcmm12317-sup-0005-FigS5.tifimage/tif260KFigure S5 Ideograph of tumour suppressor CCDC19 in modulating cell proliferation.
jcmm12317-sup-0006-TableS1.docWord document27KTable S1 siRNAs for CCDC19.
jcmm12317-sup-0007-TableS2.docWord document28KTable S2 Sequences of miR-184 mimics and negative control, miR-184 inhibitor and inhibitor negative control.
jcmm12317-sup-0008-TableS3.docWord document26KTable S3 Sequences of miR-184 and U6.
jcmm12317-sup-0009-TableS4.docWord document25KTable S4 Primer sequences for C-MYC CDS.
jcmm12317-sup-0010-TableS5.docWord document27KTable S5 ChIP Primer sequences for miR-184 promoter.
jcmm12317-sup-0011-TableS6.docWord document26KTable S6 Down-regulation of NESG1 protein in NPC compared to NP epithelium tissues.
jcmm12317-sup-0012-TableS7.docWord document55KTable S7 Correlation between the clinicopathological characteristics and expression of NESG1 protein in lung cancer.
jcmm12317-sup-0013-TableS8.docWord document56KTable S8 Summary of univariate and multivariate Cox regression analysis of overall survival duration.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.